Skip to main content

Table 4 Comparison of CMT between Ozurdex and triamcinolone at each follow up visit

From: Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

 

Ozu (n = 20) mean CMT-µm

Versus Baseline; P value

Tri (n = 20) mean CMT-µm

Versus baseline; P value

Ozu versus Tri P value

Baseline

555

552

0.5362

4 weeks

450

0.0050*

402

0.0050*

0.4254

8 weeks

350

0.0050*

330

0.0050*

0.4037

12 weeks

270

0.0049*

240

0.0050*

0.6201

24 weeks

232

0.0050*

230

0.0050*

0.4244

  1. *Statistically significant